Patents by Inventor Umberto Dianzani

Umberto Dianzani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ligands of B7H receptor in the treatment of osteopenia and osteoporosis
    Patent number: 11230587
    Abstract: A novel use of ligands of B7h receptor in the treatment of osteoporosis or osteopenia is disclosed as well as the use of B7h receptor as target for the screening of pharmaceutical active agents useful in the treatment of osteopenia or osteoporosis.
    Type: Grant
    Filed: May 18, 2016
    Date of Patent: January 25, 2022
    Assignee: UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE “AMEDEO AVOGADRO”
    Inventors: Umberto Dianzani, Casimiro Luca Gigliotti, Elena Boggio
  • ANTI-TUMOR THERAPEUTIC AGENTS BASED ON B7H RECEPTOR LIGANDS
    Publication number: 20210128684
    Abstract: Novel anti-tumor agents comprising at least one ligand of the B7h receptor, wherein the ligand of receptor B7h is loaded in a biocompatible micro- or nano-carrier and is able of binding to receptor B7h and triggering receptor B7h activity.
    Type: Application
    Filed: January 9, 2019
    Publication date: May 6, 2021
    Inventors: Umberto DIANZANI, Casimiro Luca GIGLIOTTI, Elena BOGGIO, Nausicaa CLEMENTE, Annalisa CHIOCCHETTI, Francesco TROTTA, Roberta CAVALLI, Chiara DIANZANI
  • LIGANDS OF B7H RECEPTOR IN THE TREATMENT OF OSTEOPENIA AND OSTEOPOROSIS
    Publication number: 20180305436
    Abstract: A novel use of ligands of B7h receptor in the treatment of osteoporosis or osteopenia is disclosed as well as the use of B7h receptor as target for the screening of pharmaceutical active agents useful in the treatment of osteopenia or osteoporosis.
    Type: Application
    Filed: May 18, 2016
    Publication date: October 25, 2018
    Inventors: Umberto Dianzani, Casimiro Luca GIGLIOTTI, Elena BOGGIO
  • Antiviral compositions comprising a multiple branched peptide construct containing human CD38 leukocyte surface antigen polypeptides
    Patent number: 8080633
    Abstract: Peptides representing sequences from region 45-74 of the human CD38 leukocyte surface antigen (SEQ ID NO:1) are provided which may be used to inhibit or prevent transmission or replication of the HIV virus. The peptides have from 13 to 30 amino acids and include the amino acid sequence GPGTTK (SEQ ID NO:18) for topical application to inhibit or prevent transmission of the HIV virus.
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: December 20, 2011
    Inventors: Andrea Savarino, Umberto Dianzani
  • Microbicidal compositions comprising human CD38 polypeptides derived from the extracellular membrane-proximal region
    Patent number: 8030444
    Abstract: Peptides representing sequences from region 45-74 of the human CD38 leukocyte surface antigen (SEQ ID NO:1) are provided which may be used to inhibit or prevent transmission or replication of the HIV virus. The peptides have from 13 to 30 amino acids and include the amino acid sequence GPGTTK (SEQ ID NO:18) for topical application to inhibit or prevent transmission of the HIV virus.
    Type: Grant
    Filed: August 1, 2008
    Date of Patent: October 4, 2011
    Assignee: Jarrow Formulas, Inc.
    Inventors: Andrea Savarino, Umberto Dianzani
  • CONVEX BOTTOM MICROWELL
    Publication number: 20100028935
    Abstract: Convex-bottom microwells for laboratory use in optical analyses of colorimetric or enzymological type useful for avoiding interferences with the luminous beam of the detecting instrument by corpuscular elements present in the sample to be analysed.
    Type: Application
    Filed: November 19, 2007
    Publication date: February 4, 2010
    Inventors: Carlo Ciaiolo, Marcella Rebola, Silvano Battaglio, Alessandro Valerio, Claudio Santoro, Annalisa Ciocchetti, Umberto Dianzani, Emanuele Albano
  • COMPOSITIONS CONTAINING ANTI-HIV PEPTIDES AND METHODS FOR USE
    Publication number: 20090170764
    Abstract: Peptides representing sequences from region 45-74 of the human CD38 leukocyte surface antigen are provided which may be used to inhibit or prevent transmission or replication of the HIV virus. The peptides have from 13 to 30 amino acids and include the amino acid sequence GPGTTK (SEQ ID for topical application to inhibit or prevent transmission of the HIV virus.
    Type: Application
    Filed: April 4, 2008
    Publication date: July 2, 2009
    Inventors: Andrea Savarino, Umberto Dianzani
  • Compositions containing anti-HIV peptides and methods for use
    Patent number: 7553926
    Abstract: Peptides representing sequences from region 45-74 of the human CD38 leukocyte surface antigen (SEQ ID NO:1) are provided which may be used to inhibit or prevent transmission or replication of the HIV virus. The peptides have from 13 to 30 amino acids and include the amino acid sequence GPGTTK (SEQ ID NO:18) for topical application to inhibit or prevent transmission of the HIV virus.
    Type: Grant
    Filed: April 23, 2003
    Date of Patent: June 30, 2009
    Inventors: Andrea Savarino, Umberto Dianzani
  • COMPOSITIONS CONTAINING ANTI-HIV PEPTIDES AND METHODS FOR USE
    Publication number: 20090088381
    Abstract: Peptides representing sequences from region 45-74 of the human CD38 leukocyte surface antigen (SEQ ID NO:1) are provided which may be used to inhibit or prevent transmission or replication of the HIV virus. The peptides have from 13 to 30 amino acids and include the amino acid sequence GPGTTK (SEQ ID NO:18) for topical application to inhibit or prevent transmission of the HIV virus.
    Type: Application
    Filed: August 1, 2008
    Publication date: April 2, 2009
    Inventors: ANDREA SAVARINO, Umberto Dianzani
  • Compositions containing anti-HIV peptides and methods for use
    Publication number: 20040116653
    Abstract: Peptides representing sequences from region 45-74 of the human CD38 leukocyte surface antigen are provided which may be used to inhibit or prevent transmission or replication of the HIV virus. The peptides have from 13 to 30 amino acids and include the amino acid sequence GPGTTK (SEQ ID for topical application to inhibit or prevent transmission of the HIV virus.
    Type: Application
    Filed: April 23, 2003
    Publication date: June 17, 2004
    Inventors: Andrea Savarino, Umberto Dianzani